A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
Clinical trial NCT07468396 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07468396
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2031-10-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.